Lauren A. Hodsdon

Blood-Based Surveillance Monitoring of Circulating Tumor DNA From Patients With SCLC Detects Disease Relapse and Predicts Death in Patients With Limited-Stage Disease

T. Shaffer, C. Lovly, Ying Yan, 2020, JTO clinical and research reports.

The unattainable criteria for new infant vaccines

K. O'Brien, C. Gill, M. Santosham, 2017, Human vaccines & immunotherapeutics.

Circulating Tumor DNA as a Biomarker of Radiographic Tumor Burden in SCLC

P. Massion, S. Antic, T. Shaffer, 2020, JTO clinical and research reports.